COVID: 90% of patients treated with new Israeli drug discharged in 5 days 0 05.08.2021 19:21 The Jerusalem Post The Phase II trial for an Israeli COVID drug confirmed the results of Phase I, which was conducted in Israel last winter and saw some 29 out of 30 patients moderate to serious recover within days. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
